The pharmaceutical and biotechnology industries are witnessing a rapid transformation with the growing adoption of advanced therapeutic molecules, including peptides and oligonucleotides. Increasing demand for targeted therapies, personalized medicine, and innovative treatments for chronic and rare diseases is creating significant opportunities for specialized contract development and...